<DOC>
	<DOCNO>NCT02668497</DOCNO>
	<brief_summary>The primary objective study efficacy botulinum toxin type A ( BoNT-A ) inject via kinematic parameter treatment unilateral/bilateral upper extremity tremor Parkinson 's disease ( PD ) tremor . Kinematic assessment tool already develop past clinical study use determine injection parameter . The objective study composition PD tremor use kinematic tool may contribute knowledge tremor complexity contribute information would benefit development injection parameter improve efficacy optimization BoNT-A tremor management . By inject bothersome tremulous upper limb Parkinson 's disease patient , investigator believe great improvement Quality Life daily task achieve compare investigator 's early study unilateral injection ( REB # 101749 ) , already show significant improvement .</brief_summary>
	<brief_title>Kinematic Characterization Upper Limb Parkinson 's Disease Tremor Optimized Botulinum Toxin Type A Therapy</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>PD individual diagnose UK Brain Bank Criteria stage H &amp; Y23 disease PD participant naïve PD medication group `` De novo '' PD group PD participant stable low dose Levodopa PD medication least 3 month prior study enrolment group `` Ldopa '' PD group Participants botulinum toxin naïve tremor management Patients screen pregnancy physician Individuals PD eligible study tremor primary bothersome symptom determine clinical exam patient report denote tremordominant phenotype Participants must able provide inform consent complete study assessment scale task . History stroke History ALS Myasthenia Gravis History COPD emphysema Underlying arm muscle weakness relate compartmental muscle syndrome Offending medication ( Lithium , valproate , steroid , amiodarone , betaadrenergic agonist ( e.g . salbutamol ) . Persons prescribe zonisamide History allergic side effect reaction botulinum toxin Contraindications per BoNTA drug monograph Women reporting pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Movement disorder</keyword>
	<keyword>Botulinum toxin type A</keyword>
	<keyword>Tremor</keyword>
	<keyword>Kinematics</keyword>
</DOC>